|
2003 Journal Article Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expressionVuckovic, S., Kim, M., Turtle, C. J., Khalil, D., Crosbie, G.V., Williams, K., Williams, N., Brown, L., Kelly, C., Stravos, P., Rodwell, R., Hill, G., Wright, S. J., Taylor, K., Gill, D., Marlton, P., Bradstock, K. and Hart, D. N. J. (2003). Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood, 101 (6), 2314-2317. doi: 10.1182/blood-2002-03-0973 |
|
2003 Journal Article Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantationMacDonald, Kelli P. A., Rowe, Vanessa, Filippich, Cheryl, Thomas, Ranjeny, Clouston, Andrew D., Welply, Joseph K., Hart, Derek N. J., Ferrara, James L. M. and Hill, Geoffrey R. (2003). Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation. Blood, 101 (5), 2033-2042. doi: 10.1182/blood-2002-05-1529 |
|
2002 Journal Article Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis - A missed opportunity for induction CNS prophylaxisWellwood, J, Taylor, K, Wright, S, Bentley, M, Hill, G, Phan, H, Norris, D and Livsey, R (2002). Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis - A missed opportunity for induction CNS prophylaxis. Leukemia & Lymphoma, 43 (4), 893-896. doi: 10.1080/10428190290017060 |
|
2002 Journal Article Keratinocyte Growth factor (KGF) in hematology and oncologyMacDonald, KPA and Hill, GR (2002). Keratinocyte Growth factor (KGF) in hematology and oncology. Current Pharmaceutical Design, 8 (5), 395-403. doi: 10.2174/1381612023396104 |
|
2001 Journal Article LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantationCooke, KR, Gerbitz, A, Crawford, JM, Teshima, T, Hill, GR, Tesolin, A, Rossignol, DP and Ferrara, JLM (2001). LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. Journal of Clinical Investigation, 107 (12), 1581-1589. doi: 10.1172/JCI12156 |
|
2001 Journal Article Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantationTeshima, T, Mach, N, Hill, GR, Pan, LY, Gillessen, S, Dranoff, G and Ferrara, JLM (2001). Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer Research, 61 (1), 162-171. |
|
2000 Journal Article Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: Potential role for a gut-lung axis of inflammationCooke, KR, Hill, GR, Gerbitz, A, Kobzik, L, Martin, TR, Crawford, JM, Brewer, JP and Ferrara, JLM (2000). Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: Potential role for a gut-lung axis of inflammation. Journal of Immunology, 165 (11), 6612-6619. doi: 10.4049/jimmunol.165.11.6612 |
|
2000 Journal Article Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantationCooke, KR, Hill, GR, Gerbitz, A, Kobzik, L, Martin, TR, Crawford, JM, Brewer, JP and Ferrara, JLM (2000). Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation, 70 (2), 272-279. doi: 10.1097/00007890-200007270-00006 |
|
2000 Journal Article The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantationHill, GR and Ferrara, JLM (2000). The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood, 95 (9), 2754-2759. |
|
2000 Journal Article G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipientReddy, , Hill, GR, Pan, LY, Gerbitz, A, Teshima, T, Brinson, Y and Ferrara, JLM (2000). G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation, 69 (4), 691-693. doi: 10.1097/00007890-200002270-00041 |
|
2000 Journal Article The p55 TNF-alpha receptor plays a critical role in T cell alloreactivityHill, GR, Teshima, T, Rebel, , Krijanovski, OI, Cooke, KR, Brinson, YS and Ferrara, JLM (2000). The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity. Journal of Immunology, 164 (2), 656-663. doi: 10.4049/jimmunol.164.2.656 |
|
2000 Journal Article Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptideSnowden, JA, Hill, GR, Hunt, P, Carnoutsos, S, Spearing, RL, Espiner, E and Hart, DNJ (2000). Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide. Bone Marrow Transplantation, 26 (3), 309-313. doi: 10.1038/sj.bmt.1702507 |
|
1999 Journal Article Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell levelRebel, , Hartnett, S, Hill, GR, Lazo-Kallanian, SB, Ferrara, JLM and Sieff, CA (1999). Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level. Journal of Experimental Medicine, 190 (10), 1493-1503. doi: 10.1084/jem.190.10.1493 |
|
1999 Journal Article Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemiaHill, GR, Teshima, T, Gerbitz, A, Pan, LY, Cooke, KR, Brinson, YS, Crawford, JM and Ferrara, JLM (1999). Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. Journal of Clinical Investigation, 104 (4), 459-467. doi: 10.1172/JCI6896 |
|
1999 Journal Article IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantationTeshima, T, Hill, GR, Pan, LY, Brinson, YS, van den Brink, MRM, Cooke, KR and Ferrara, JLM (1999). IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. Journal of Clinical Investigation, 104 (3), 317-325. doi: 10.1172/JCI7111 |
|
1999 Journal Article Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host diseaseKrijanovski, OI, Hill, GR, Cooke, KR, Teshima, T, Crawford, JM, Brinson, YS and Ferrara, JLM (1999). Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood, 94 (2), 825-831. |
|
1999 Journal Article Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host diseasePan, LP, Teshima, T, Hill, GR, Bungard, D, Brinson, YS, Reddy, VS, Cooke, KR and Ferrara, LM (1999). Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood, 93 (12), 4071-4078. |
|
1999 Journal Article Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantationHill, GR, Cooke, KR, Brinson, YS, Bungard, D and Ferrara, JLM (1999). Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation, 67 (11), 1478-1480. doi: 10.1097/00007890-199906150-00015 |
|
1999 Journal Article Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myelomaHart, D. N. J. and Hill, G. R. (1999). Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma. Immunology and Cell Biology, 77 (5), 451-459. doi: 10.1046/j.1440-1711.1999.00859.x |
|
1998 Journal Article Congenital dyserythropoiesis with intererythroblastic chromatin bridges and ultrastructurally-normal erythroblast heterochromatin: a new disorderWickramashinghe, SN, Spearing, RL and Hill, GR (1998). Congenital dyserythropoiesis with intererythroblastic chromatin bridges and ultrastructurally-normal erythroblast heterochromatin: a new disorder. British Journal of Haematology, 103 (3), 831-834. |
